Previous research has demonstrated that SEC23B mutations may cause congenital dyserythropoietic anemia type II (CDAII) [7], while the mutations of SEC23A may cause cranio-lenticulo-sutural dysplasia (CLSD) [8]. Here, SEC23B is linked to Congenital dyserythropoietic anemia type II.